Publication:
Hematopoietic growth factor family for stroke drug development

Placeholder

Departments

Organizational Unit

School / College / Institute

Organizational Unit
SCHOOL OF MEDICINE
Upper Org Unit

Program

KU Authors

Co-Authors

Digiçaylıoğlu, Murat

Publication Date

Language

Embargo Status

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

Hematopoietic growth factors (HGFs) are a family of cytokines that play important roles in the survival, proliferation, and differentiation of hematopoietic progenitors, as well as in the functional activation of mature cells. However, there is a growing body evidences have suggested that HGFs have important non-hematopoietic functions in the central nervous system. Preclinical studies have demonstrated significant benefits from the use of these cytokines in the acute and chronic treatment of various neurological disorders. Unfortunately, the efficacy of these candidate neuroprotectants in animal experiments does not reliably predict efficacy in stroke patients. This chapter presents a broad overview of data from preclinical neuroprotection and clinical trial studies.

Source

Publisher

Springer

Subject

Clinical neuropsychology, neurosciences

Citation

Has Part

Source

Translational Stroke Research: From Target Selection To Clinical Trials

Book Series Title

Edition

DOI

10.1007/978-1-4419-9530-8_12

item.page.datauri

Link

Rights

Copyrights Note

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads

View PlumX Details